A detailed history of Buckingham Strategic Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Buckingham Strategic Wealth, LLC holds 20,767 shares of LLY stock, worth $16.5 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
20,767
Previous 20,663 0.5%
Holding current value
$16.5 Million
Previous $16.1 Million 16.97%
% of portfolio
0.21%
Previous 0.18%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $75,386 - $94,540
104 Added 0.5%
20,767 $18.8 Million
Q1 2024

May 09, 2024

SELL
$592.2 - $792.28 $1.96 Million - $2.62 Million
-3,305 Reduced 13.79%
20,663 $16.1 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $518,887 - $611,700
-988 Reduced 3.96%
23,968 $14 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $74,333 - $102,480
171 Added 0.69%
24,956 $13.4 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $4.27 Million - $5.72 Million
12,187 Added 96.74%
24,785 $11.6 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $360,136 - $419,630
-1,120 Reduced 8.16%
12,598 $4.61 Million
Q3 2022

Nov 07, 2022

SELL
$296.48 - $337.87 $231,847 - $264,214
-782 Reduced 5.39%
13,718 $4.44 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $84,733 - $99,490
304 Added 2.14%
14,500 $4.7 Million
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $170,854 - $212,328
-728 Reduced 4.88%
14,196 $4.07 Million
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $14,390 - $17,858
64 Added 0.43%
14,924 $4.12 Million
Q3 2021

Nov 10, 2021

SELL
$221.6 - $272.71 $25,484 - $31,361
-115 Reduced 0.77%
14,860 $3.43 Million
Q2 2021

Aug 06, 2021

SELL
$180.55 - $233.54 $118,440 - $153,202
-656 Reduced 4.2%
14,975 $3.44 Million
Q1 2021

Apr 30, 2021

BUY
$164.32 - $212.72 $13,309 - $17,230
81 Added 0.52%
15,631 $2.92 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $1.2 Million - $1.58 Million
9,172 Added 143.81%
15,550 $2.63 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $50,007 - $57,842
342 Added 5.67%
6,378 $944,000
Q2 2020

Aug 03, 2020

SELL
$136.42 - $164.18 $296,713 - $357,091
-2,175 Reduced 26.49%
6,036 $991,000
Q1 2020

May 07, 2020

BUY
$119.05 - $147.35 $121,788 - $150,739
1,023 Added 14.23%
8,211 $1.14 Million
Q4 2019

Feb 04, 2020

BUY
$106.92 - $132.43 $123,064 - $152,426
1,151 Added 19.07%
7,188 $945,000
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $28,299 - $30,782
-265 Reduced 4.21%
6,037 $675,000
Q2 2019

Aug 05, 2019

BUY
$110.79 - $129.32 $192,109 - $224,240
1,734 Added 37.96%
6,302 $698,000
Q1 2019

May 02, 2019

BUY
$111.31 - $131.02 $82,480 - $97,085
741 Added 19.36%
4,568 $593,000
Q4 2018

Feb 11, 2019

BUY
$105.9 - $118.64 $13,978 - $15,660
132 Added 3.57%
3,827 $443,000
Q3 2018

Nov 02, 2018

SELL
$85.86 - $107.31 $200,998 - $251,212
-2,341 Reduced 38.78%
3,695 $397,000
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $159,575 - $183,143
2,108 Added 53.67%
6,036 $515,000
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $3,265 - $3,854
44 Added 1.13%
3,928 $304,000
Q4 2017

Feb 12, 2018

BUY
$81.94 - $87.89 $45,886 - $49,218
560 Added 16.85%
3,884 $328,000
Q3 2017

Nov 08, 2017

BUY
$77.07 - $85.54 $256,180 - $284,334
3,324
3,324 $284,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Buckingham Strategic Wealth, LLC Portfolio

Follow Buckingham Strategic Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Strategic Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Strategic Wealth, LLC with notifications on news.